To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3937 | Ouabain |
Natural inhibitor of the Na+/K+-ATPase sodium-potassium ion pump
More description
|
|
| DCC3936 | Ota-5781 |
Novel potent inhibitor of the natural function of FDX1, promoting a unique form of copper-dependent cell death
More description
|
|
| DCC3935 | Osu-53 |
Novel AMPK activator, inhibiting mTOR signaling and autophagy stimulation, activating mutations in RAS or BRAF
More description
|
|
| DCC3934 | Osteosarcoma-in-d15 |
Novel Inhibitor of Migration and Invasion of Osteosarcoma Cells Mediated by p53, Regulating EMT-Related Genes
More description
|
|
| DCC3933 | Osteosarcoma-in-d14 |
Novel Inhibitor of Migration and Invasion of Osteosarcoma Cells Mediated by p53, Regulating EMT-Related Genes
More description
|
|
| DCC3932 | Osteoprotegerin |
Soluble secreted member of the tumor necrosis factor receptor superfamily, inhibiting osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, leading to excess accumulation of bone and cartilage
More description
|
|
| DCC3931 | Osteoclast Differentiation Inhibitor T63 |
Novel inhibitor of osteoclast differentiation through regulating MAPKs and Akt signaling pathways
More description
|
|
| DCC3930 | Osl-95ii |
Inhibitor of the glycan-processing enzyme endoplasmic-reticular glucosidase
More description
|
|
| DCC3929 | Osi-461 |
Novel cGMP phosphodiesterase (cGMP-PDE) inhibitor
More description
|
|
| DCC3928 | Osi-296 |
Novel potent, orally efficacious, dual inhibitor of cMET and RON kinases
More description
|
|
| DCC3927 | Oseltamivir Hydrochloride |
Inhibitor of the influenza neuramidase enzyme, blocking neuraminidases on the surfaces of influenza viruses, interfering with host cell release of complete viral particles
More description
|
|
| DCC3926 | Ortataxel |
Second-generation taxane derivative with potential antineoplastic activity, binding to and stabilizing tubulin molecules, inhibiting cell division and cellular proliferation
More description
|
|
| DCC3925 | Orp-101 |
Peripheral weak partial mu-opioid receptor agonist and a weak kappa-opioid receptor antagonist, preventing from being absorbed and entering the central nervous system
More description
|
|
| DCC3924 | Oroidin Hydrochloride |
Inhibitor of an enzyme responsible for the multidrug resistance phenotype in the yeast Saccharomyces cerevisiae.
More description
|
|
| DCC3923 | Orn0829 |
Novel potent dual orexin 1/2 receptor (OX1/2R) antagonist for the treatment of insomnia
More description
|
|
| DCC3922 | orm-10103 |
Novel sodium/calcium exchanger (NCX) inhibitor
More description
|
|
| DCC3921 | Oritavancin |
Lipoglycopeptide Antibacterial, acting as a inhibitor of Cytochrome P450 2C19/2C9, and a inducer of Cytochrome P450 3A4/2D6
More description
|
|
| DCC3920 | Org48762-0 |
Selective p38alpha and p38beta kinase inhibitor
More description
|
|
| DCC3919 | Org-29647 |
CB1 allosteric modulator
More description
|
|
| DCC3918 | Org-27759 |
Negative allosteric modulator at the CB1 receptor
More description
|
|
| DCC3917 | Orex-1019 |
Novel mixed κ/μ receptor antagonist. having therapeutic potential for the treatment of depression and other stress-induced conditions
More description
|
|
| DCC3916 | Orcein |
Collagen immunostain
More description
|
|
| DCC3915 | Orc-13661 Hydrochloride |
Novel Potent, Well Tolerated, and Orally Active Protective Agent against Aminoglycoside-Induced Hearing Loss
More description
|
|
| DCC3914 | Optoglunam4.1 |
Novel negative allosteric modulator (NAM) of mGlu4, being isomerized with blue-light/dark cycles with fast relaxation
More description
|
|
| DCC3913 | Ophiobolin A |
Inhibitor of calmodulin action in calcium regulation
More description
|
|
| DCC3912 | Opc-14117 |
Antioxidant and free radical scavenger, attenuating edema formation, and subsequent tissue damage following cortical contusion
More description
|
|
| DCC3911 | Opc-13213 |
Metabolite of Cilostazol
More description
|
|
| DCC3910 | Oopz-23-l(nle)aq |
Novel potent inhibitor of protein-protein interactions
More description
|
|
| DCC3909 | Ono-ae3-237 |
Potent, selective, and orally active prostaglandin D2 receptor antagonist
More description
|
|
| DCC3908 | Ono-ae-248 |
Novel selective EP3 receptor agonist
More description
|
|